Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB11450ExperimentalVet approvedSmall molecule
Pimobendan: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Phosphodiesterase 3
- Formula / weight
- C19H18N4O2 · 334.379 g/mol (avg)
- Also known as
- dl-Pimobendan
- Code names
- UDCG-115
Resolves to
Clinical / RWD
Structure
InChIKey
GLBJJMFZWDBELO-UHFFFAOYSA-NSMILESCOC1=CC=C(C=C1)C1=NC2=CC(=CC=C2N1)C1=NNC(=O)CC1CWhat you can answer from here — as of July 07, 2026
Which companies are running trials of Pimobendan, in which indications and phases, and which of those programs are still active?